Pharmaceutical Maneuvers: Europe's Drug Delays Amidst Trump's Price War
Published on: April 2, 2026, 2:34 a.m. | Source: Devdiscourse
Recent health news highlights key events impacting the pharmaceutical sector. European drug launches face delays due to pricing pressures from former US President Donald Trump. The FDA warns of liver injury associated with Amgen's drug. Additionally, investor activism and strategic maneuvers reveal the ongoing dynamics within major pharma companies.
